1. Home
  2. TRAK vs NERV Comparison

TRAK vs NERV Comparison

Compare TRAK & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

N/A

Current Price

$7.15

Market Cap

157.2M

Sector

Technology

ML Signal

N/A

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

N/A

Current Price

$2.22

Market Cap

166.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRAK
NERV
Founded
1990
2007
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
166.4M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
TRAK
NERV
Price
$7.15
$2.22
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
69.0K
★ 127.1K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
★ 1.11%
N/A
EPS Growth
★ 11.43
N/A
EPS
★ 0.39
N/A
Revenue
$21,007,076.00
★ $41,175,600.00
Revenue This Year
$9.50
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
$18.38
★ N/A
Revenue Growth
★ 4.84
N/A
52 Week Low
$6.94
$2.12
52 Week High
$15.44
$8.80

Technical Indicators

Market Signals
Indicator
TRAK
NERV
Relative Strength Index (RSI) 35.65 28.78
Support Level $6.98 N/A
Resistance Level $9.06 $5.69
Average True Range (ATR) 0.22 0.23
MACD -0.01 0.01
Stochastic Oscillator 24.13 11.71

Price Performance

Historical Comparison
TRAK
NERV

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: